PMV Pharmaceuticals PMVP Income Statement (2019-2026)

NASDAQ PMVP
$1.30 +0.02 (+1.56%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
7.66M9.16M12.17M11.84M11.46M13.67M15.03M15.07M13.84M13.59M13.38M13.19M14.63M16.95M13.77M17.44M18.40M18.21M15.83M15.33M
Selling, General & Administrative (Quarter)
5.39M5.93M6.30M6.78M6.42M5.71M6.14M6.41M6.28M6.04M5.52M5.04M5.54M4.94M11.40M4.12M4.48M4.31M3.42M3.69M
Operating Expenses (Quarter)
13.05M15.10M18.47M18.62M17.89M19.38M21.16M21.48M20.12M19.63M18.90M18.22M20.17M21.89M25.17M21.56M22.88M22.52M19.24M19.02M
Operating Income (Quarter)
-13.05M-15.10M-18.47M-18.62M-17.89M-19.38M-21.16M-21.48M-20.12M-19.63M-18.90M-18.22M-20.17M-21.89M-25.17M-21.56M-22.88M-22.52M-19.24M-19.02M
EBIT (Quarter)
-13.05M-15.10M-18.47M-18.62M-17.89M-19.38M-21.16M-21.48M-20.12M-19.63M-18.90M-18.22M-20.17M-21.89M-25.17M-21.56M-22.88M-22.52M-19.24M-19.02M
Non-operating items
Other Non Operating Income (Quarter)
0.06M0.10M-0.34M0.19M0.57M1.14M-1.81M2.35M2.69M2.99M3.15M-0.00M-0.02M0.12M-8.49M-0.00M1.67M1.46M-5.11M0.98M
Net income details
EBT (Quarter)
-12.87M-14.99M-18.36M-18.43M-17.31M-18.24M-19.34M-19.13M-17.43M-16.64M-15.76M-15.27M-17.39M-19.15M-23.10M-19.63M-21.20M-21.07M-18.03M-18.04M
Tax Provisions (Quarter)
0.02M0.00M-0.00M-0.01M0.00M-0.00M-0.00M-16.17M0.07M-2.20M0.01M-0.01M0.03M
Profit After Tax (Quarter)
-12.87M-15.01M-18.37M-18.43M-17.31M-18.23M-19.71M-19.13M-17.44M-16.67M-15.76M-15.27M-1.21M-19.23M-23.00M-17.44M-21.21M-21.06M-17.99M-18.04M
Income from Non-Controlling Interests (Quarter)
0.02M0.01M-0.09M-0.59M-0.36M-0.00M0.58M0.33M-0.21M-0.03M0.55M-0.32M-0.06M0.59M-0.26M-0.06M-0.06M0.07M-0.01M-0.10M
Income from Continuing Operations (Quarter)
-12.87M-15.01M-18.36M-18.43M-17.31M-18.23M-19.34M-19.13M-17.44M-16.64M-15.76M-15.27M-1.21M-19.23M-23.10M-17.44M-21.21M-21.06M-18.06M-18.04M
Consolidated Net Income (Quarter)
-12.87M-15.01M-18.36M-18.43M-17.31M-18.23M-19.34M-19.13M-17.44M-16.64M-15.76M-15.27M-1.21M-19.23M-23.10M-17.44M-21.21M-21.06M-18.06M-18.04M
Income towards Parent Company (Quarter)
-12.87M-15.01M-18.36M-18.43M-17.31M-18.23M-19.34M-19.13M-17.44M-16.64M-15.76M-15.27M-1.21M-19.23M-23.10M-17.44M-21.21M-21.06M-18.06M-18.04M
Net Income towards Common Stockholders (Quarter)
-12.87M-15.01M-18.36M-18.43M-17.31M-18.23M-19.34M-19.13M-17.44M-16.64M-15.76M-15.27M-1.21M-19.23M-23.10M-17.44M-21.21M-21.06M-18.06M-18.04M
Additional items
EPS (Basic) (Quarter)
-0.29-0.33-0.41-0.41-0.38-0.40-0.42-0.42-0.38-0.34-0.33-0.30-0.02-0.37-0.45-0.34-0.41-0.40-0.34-0.34
EPS (Diluted) (Quarter)
-0.90-0.33-0.41-0.41-0.38-0.40-0.42-0.42-0.38-0.34-0.33-0.30-0.02-0.37-0.45-0.34-0.41-0.40-0.34-0.34
Shares Outstanding (Quarter)
45.07M45.30M45.14M45.47M45.57M45.62M45.59M45.77M45.81M49.05M48.01M51.45M51.48M51.57M51.58M51.95M52.01M52.99M52.54M53.33M
Shares Outstanding (Diluted) (Quarter)
14.36M45.30M45.14M45.47M45.57M45.62M45.59M45.77M45.81M49.05M48.01M51.45M51.48M51.57M51.58M51.95M52.01M52.99M52.54M53.33M
Shares Outstanding (Entity) (Quarter)
45.21M45.35M45.43M45.53M45.62M45.62M45.77M45.77M46.14M51.16M51.45M51.45M51.52M51.75M51.94M51.95M52.99M52.99M53.33M53.33M
EBITDA (Quarter)
-13.05M-15.10M-18.47M-18.62M-17.89M-19.38M-21.16M-21.48M-20.12M-19.63M-18.90M-18.22M-20.17M-21.89M-25.17M-21.56M-22.88M-22.52M-19.24M-19.02M
Interest Expenses (Quarter)
116.31M94.08M0.18M63.62M36.33M28.40M17.24M5.61M11.01M9.94M0.99M3.38M3.19M3.23M0.16M0.25M0.21M0.42M0.09M0.08M
Tax Rate (Quarter)
-0.13%-0.01%0.01%0.05%-0.02%0.01%0.01%93.02%-0.39%11.19%-0.02%0.03%-0.14%